Records containing: Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-03-06Immunization of Disease-Free Melanoma Patients With Different HLA-A2 Peptides
-
CLINICAL_TRIALS study record update · 2019-02-21Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration
-
CLINICAL_TRIALS study record update · 2019-02-18Phase II Biomarker Study Evaluating The Upfront Combination Of BRAF Inhibitor Dabrafenib With MEK Inhibitor Trametinib Versus The Combination After Eight Weeks Of Monotherapy With Dabrafenib Or Trametinib In Patients With Metastatic And Unresectable Stage III Or IV Melanoma Harbouring An Activating BRAF Mutation
-
CLINICAL_TRIALS study record update · 2019-02-15An Open-Label, Multicenter Dose-Escalation Study to Evaluate the Safety and Tolerability of AP 12009 (Trabedersen), Administered Intravenously in Patients With Advanced Tumors Known to Overproduce TGF-β2.
-
CLINICAL_TRIALS study record update · 2019-02-08PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-02-08Using High Resolution Function Imaging To Detect Melanoma and Dysplastic Nevi
-
CLINICAL_TRIALS study record update · 2019-01-30A Pilot Study of Trientine With Vemurafenib for the Treatment BRAF Mutated Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2019-01-30An Observational Study to Evaluate the Effectiveness and Safety of Ipilimumab, Administered During the European Expanded Access Programme in Pretreated Patients With Advanced (Unresectable or Metastatic) Melanoma
-
CLINICAL_TRIALS study record update · 2019-01-30ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTS
-
CLINICAL_TRIALS study record update · 2019-01-22Survival in Adult Patients With BRAF V600 Mutation-Positive Advanced Melanoma: A Non-Interventional Ambispective Study of a Cohort of Patients Treated With Cobimetinib During the French Early Access Program (TAU)
-
CLINICAL_TRIALS study record update · 2019-01-10Phase III Open Label Trial for Use of [18F]-Fluoro-Deoxy-Glucose (18F-FDG) in Positron Emission Tomography Imaging in Oncology
-
CLINICAL_TRIALS study record update · 2019-01-10SAbR-Induced Innate Immunity in Urothelial Carcinoma, Melanoma, and Cervical Carcinoma
-
CLINICAL_TRIALS study record update · 2019-01-08Expansion ex Vivo Des Cellules Tumorales Circulantes Comme modèle de Pharmacologie prédictive Des Cancers. EXPEVIVO-CTC
-
CLINICAL_TRIALS study record update · 2019-01-08Phase IIIb, Randomized, Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Previously Untreated Unresectable or Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2019-01-04Adjuvant Immunotherapy With Anti-PD-1 Monoclonal Antibody Pembrolizumab (MK-3475) Versus Placebo After Complete Resection of High-risk Stage III Melanoma: A Randomized, Double- Blind Phase 3 Trial of the EORTC Melanoma Group
-
CLINICAL_TRIALS study record update · 2019-01-04Pilot Study to Evaluate the Signaling Pathway Modulation Demonstrated by Raf, MEK, and Kinase Inhibitors In Human Skin With or Without Solar Simulated Light
-
CLINICAL_TRIALS study record update · 2018-12-27A Phase 1/2, Multicenter, Open-label, Dose-finding Study to Assess the Safety, Tolerability, and Preliminary Efficacy of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent or Refractory Solid Tumors.
-
CLINICAL_TRIALS study record update · 2018-12-19Skin Care Behaviors Among Melanoma Survivors and Their Families
-
CLINICAL_TRIALS study record update · 2018-11-20Circulating Tumor DNA Exposure in Peripheral Blood Using a Novel Process: A Feasibility Study
-
CLINICAL_TRIALS study record update · 2018-11-16Validation of Mobile Technologies for Clinical Assessment, Monitoring, and Intervention (SBIR Topic 342, Direct to Phase II- Vignet, Inc.)
-
CLINICAL_TRIALS study record update · 2018-11-14A Phase I Study of Temozolomide, Thalidomide, and Lomustine (TTL) in Patients With Metastatic Melanoma in the Brain
-
CLINICAL_TRIALS study record update · 2018-11-09A Parallel Phase I/II Study of Low Dose Decitabine (5-Aza-Deoxycytidine) With Peginterferon Alfa-2b in Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2018-11-07Analysis of the Kinetics and Effects of Vemurafenib + Cobimetinib on Intratumoral and Host Immunity in Patients With Advanced BRAFV600 Mutant Melanoma: Implications for Combination With Immunotherapy
-
CLINICAL_TRIALS study record update · 2018-10-31Phase II Trial of Gleevec (Imatinib Mesylate, STI-571) in Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2018-10-17A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Vemurafenib (RO5185426) Adjuvant Therapy in Patients With Surgically Resected, Cutaneous BRAF-Mutant Melanoma at High Risk for Recurrence